miR-126-3p contributes to sorafenib resistance in hepatocellular carcinoma via downregulating SPRED1 (vol 9, 38, 2021)

被引：2
|
作者：
不详
机构：
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2022年
关键词：
D O I：
10.21037/atm-2022-34
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] miR-126-3p contributes to sorafenib resistance in hepatocellular carcinoma via downregulating SPRED1
    Tan, Wenliang
    Lin, Zhirong
    Chen, Xianqing
    Li, Wenxin
    Zhu, Sicong
    Wei, Yingcheng
    Huo, Liyun
    Chen, Yajin
    Shang, Changzhen
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (01)
  • [2] IFN-γ enhances the therapeutic efficacy of MSCs-derived exosome via miR-126-3p in diabetic wound healing by targeting SPRED1
    Lu, Wen
    Du, Xuan
    Zou, Shengyi
    Fang, Qionglei
    Wu, Mengjiao
    Li, Huijuan
    Shi, Bimin
    JOURNAL OF DIABETES, 2024, 16 (01)
  • [3] IFN-? enhances the therapeutic efficacy of MSCs-derived exosome via miR-126-3p in diabetic wound healing by targeting SPRED1
    Lu, Wen
    Du, Xuan
    Zou, Shengyi
    Fang, Qionglei
    Wu, Mengjiao
    Li, Huijuan
    Shi, Bimin
    JOURNAL OF DIABETES, 2023,
  • [4] miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A
    Simona Caporali
    Adriana Amaro
    Lauretta Levati
    Ester Alvino
    Pedro Miguel Lacal
    Simona Mastroeni
    Federica Ruffini
    Laura Bonmassar
    Gian Carlo Antonini Cappellini
    Nadia Felli
    Alessandra Carè
    Ulrich Pfeffer
    Stefania D’Atri
    Journal of Experimental & Clinical Cancer Research, 38
  • [5] The NUPR1/p73 axis contributes to sorafenib resistance in hepatocellular carcinoma*
    Augello, Giuseppa
    Emma, Maria Rita
    Azzolina, Antonina
    Puleio, Roberto
    Condorelli, Lucia
    Cusimano, Antonella
    Giannitrapani, Lydia
    McCubrey, James A.
    Iovanna, Juan Lucio
    Cervello, Melchiorre
    CANCER LETTERS, 2021, 519 : 250 - 262
  • [6] miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A
    Caporali, Simona
    Amaro, Adriana
    Levati, Lauretta
    Alvino, Ester
    Lacal, Pedro Miguel
    Mastroeni, Simona
    Ruffini, Federica
    Bonmassar, Laura
    Cappellini, Gian Carlo Antonini
    Felli, Nadia
    Care, Alessandra
    Pfeffer, Ulrich
    D'Atri, Stefania
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38
  • [7] circFOXM1 contributes to sorafenib resistance of hepatocellular carcinoma cells by regulating MECP2 via miR-1324
    Weng, Hanqin
    Zeng, Lexiang
    Cao, Linhui
    Chen, Tao
    Li, Yanshan
    Xu, Yunxiuxiu
    Peng, Yaorong
    Ye, Yibiao
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2021, 23 : 811 - 820
  • [8] LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells (vol 38, 183, 2019)
    Li, Weidong
    Dong, Xuesong
    He, Changjun
    Tan, Gang
    Li, Ziyi
    Zhai, Bo
    Feng, Jing
    Jiang, Xian
    Liu, Chang
    Jiang, Hongchi
    Sun, Xueying
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
  • [9] Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma
    Shao, Yu-Yun
    Chen, Pai-Sheng
    Lin, Liang-In
    Lee, Bin-Shyun
    Ling, Andrew
    Cheng, Ann-Lii
    Hsu, Chiun
    Ou, Da-Liang
    BRITISH JOURNAL OF CANCER, 2022, 126 (12) : 1806 - 1814
  • [10] Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma
    Yu-Yun Shao
    Pai-Sheng Chen
    Liang-In Lin
    Bin-Shyun Lee
    Andrew Ling
    Ann-Lii Cheng
    Chiun Hsu
    Da-Liang Ou
    British Journal of Cancer, 2022, 126 : 1806 - 1814
12345